You can buy or sell ZIOP and other stocks, options, ETFs, and crypto commission-free!
ZIOPHARM Oncology Inc Common Stock, also called Ziopharm Oncology, is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline include Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. Read More The company was founded on September 9, 2003 and is headquartered in Boston, MA.
52 Week High
52 Week Low
— per share
Expected May 6, After Hours